Breath Therapeutics
BPC181BR

Company profile Breath Therapeutics

Breath is a German/US Biotech company specializing in first-in-class therapies for rare respiratory diseases with fatal outcome and high unmet medical need. For its clinical development, the Company is using new proprietary drug formulations optimized for inhaled administration with exclusively licensed, high performance nebulizers. Breath is focusing on integrated therapy solutions in the interaction between diagnostics, therapeutics and eHealth therapy monitoring.

CO2 compensation
40,0 t CO2
Projects
1
Partner since
2019
Status
active

Supported projects

Aufforstung in den Anden Boliviens

Trees: 25.707

Company Website

http://breath-therapeutics.com

Contact

Breath Therapeutics
Frankfurt / Munich / San Francisco
contact@breath-therapeutics.com

Blue Planet Certificate BPC181BR